Part of Phaidon International
Part of Phaidon International
Showing 15 results
Sort by:
Associate Director, Advanced Analytics for Mid-Sized Pharmaceutical Company Pain Management | OrthopedicsGreater San Francisco Bay Area$180,000 - $200,000 base salary + benefits packageAbout the OpportunityWe are seeking an experienced analytics leader to join our Commercial Insights & Analytics organization as Associate Director, Advanced Analyti...
Senior / Staff Machine Learning Research EngineerLocation: San Francisco Bay Area (Hybrid)Level: Senior or StaffReports to: Head of Machine Learning The OpportunityA well-resourced, research-driven technology organization is building out a dedicated Machine Learning Research Engineering function to support the development of cutting-edge machine le...
Director, Regulatory Affairs - Structural HeartLocation: Minneapolis, MN Reports To: Vice President, Regulatory Affairs* Medical device background only Position SummaryWe are seeking a Director of Regulatory Affairs to lead global regulatory strategy and execution for a portfolio of innovative structural heart medical devices. This individual will ...
Take the first step toward your next opportunity - submit your resume and get started today.
Senior Director, Head of Clinical Pharmacology - OncologySan Francisco, California (Hybrid)Salary: 290-330,000 base + 30% bonus + RSUs + additional benefitsAbout the OpportunityOur client, a clinical-stage biotechnology company advancing innovative therapies across oncology and immunology-focused programs, is seeking an accomplished Senior Director...
EPM Scientific are working with a leading firm who are seeking a Executive Director to join their team. Reporting into the SVP of Biometrics, this is the senior-most Clinical Data Management leader within the organization. You'll own the CDM strategy, lead and develop the team, and serve as a key partner to executive leadership as the company adva...
The OpportunityThis is a rare chance to step in as the in‑region clinical operations lead for APAC at a privately backed, clinical‑stage biotech entering a decisive phase of growth. The company has moved beyond platform promise into execution - multiple programs advancing, real patients enrolling, and global timelines that now depend on strong regi...